Open access · CC-BY
via OpenAlex
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Hyemi Eo, Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine · 2024 · ▲ 44 citations
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by both motor symptoms and non-motor features. A hallmark of PD is the misfolding and accumulation of alpha-synuclein (α-syn), which triggers neuroinflammation and drives neurodegeneration. Microglia, brain cells that play a central role in neuroinflammatory responses and help clear various unnecessary molecules within the brain, thus maintaining the brain's internal environment, respond to α-syn through mechanisms involving inflammation, propagation, and clearance. This review delves into the complex interplay between α-syn and microglia, elucidating how these interactions drive PD pathogenesis. Furthermore, we discuss emerging therapeutic strategies targeting the α-syn-microglia axis, with a focus on modulating microglial functions to mitigate neuroinflammation, enhance clearance, and prevent α-syn propagation, emphasizing their potential to slow PD progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/jcm13237243
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Eo, H., Kim, S., Jung, U.J., & Kim, S.R. (2024). Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects. <em>Journal of Clinical Medicine</em>. https://doi.org/10.3390/jcm13237243
Vancouver
Eo H, Kim S, Jung UJ, Kim SR. Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects. Journal of Clinical Medicine. 2024. doi:10.3390/jcm13237243.
BibTeX
@article{hyemi2024AlphaS,
title = {Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects},
author = {Hyemi Eo and Sehwan Kim and Un Ju Jung and Sang Ryong Kim},
journal = {Journal of Clinical Medicine},
year = {2024},
doi = {10.3390/jcm13237243},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Parkinsonism & Related Disorders 2020
Citation only
Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease
Current Neurology and Neuroscience Reports 2018
Open access · CC-BY
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Glia 2022
Open access · CC-BY
Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
Frontiers in neuroendocrinology 2026
Citation only
Circadian aging and neurodegeneration: the emerging role of the melatonin-cortisol axis in brain homeostasis, disease progression, and precision chronomedicine.
Human Molecular Genetics 2007
Open access · OA
Parkinson's disease
Adelaide Research & Scholarship (AR&S) (University of Adelaide) 2024
Preprint · OA